Extended-spectrum β-lactamase- and AmpC β-lactamase-producing Enterobacterales associated with urinary tract infections in the New Zealand community: a case-control study

Int J Infect Dis. 2023 Mar:128:325-334. doi: 10.1016/j.ijid.2022.12.013. Epub 2022 Dec 16.

Abstract

Objectives: To assess whether having a pet in the home is a risk factor for community-acquired urinary tract infections associated with extended-spectrum β-lactamase (ESBL)- or AmpC β-lactamase (ACBL)- producing Enterobacterales.

Methods: An unmatched case-control study was conducted between August 2015 and September 2017. Cases (n = 141) were people with community-acquired urinary tract infection (UTI) caused by ESBL- or ACBL-producing Enterobacterales. Controls (n = 525) were recruited from the community. A telephone questionnaire on pet ownership and other factors was administered, and associations were assessed using logistic regression.

Results: Pet ownership was not associated with ESBL- or ACBL-producing Enterobacterales-related human UTIs. A positive association was observed for recent antimicrobial treatment, travel to Asia in the previous year, and a doctor's visit in the last 6 months. Among isolates with an ESBL-/ACBL-producing phenotype, 126/134 (94%) were Escherichia coli, with sequence type 131 being the most common (47/126).

Conclusions: Companion animals in the home were not found to be associated with ESBL- or ACBL-producing Enterobacterales-related community-acquired UTIs in New Zealand. Risk factors included overseas travel, recent antibiotic use, and doctor visits.

Keywords: AmpC; Antimicrobial resistance; E. coli; ESBL; Enterobacterales; Urinary tract infection.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Case-Control Studies
  • Community-Acquired Infections* / epidemiology
  • Community-Acquired Infections* / microbiology
  • Escherichia coli
  • Escherichia coli Infections* / epidemiology
  • Humans
  • New Zealand
  • Risk Factors
  • Urinary Tract Infections* / epidemiology
  • Urinary Tract Infections* / microbiology
  • beta-Lactamases / genetics

Substances

  • AmpC beta-lactamases
  • Anti-Bacterial Agents
  • beta-Lactamases